Side-by-side IPO readiness, funding history, and valuation comparison. Data sourced by TechStackIPO.
Scores, valuations, and signals for SpaceX, Spring Health, and 370+ companies. 5-min read every Tuesday.
Aerospace and defense company. Active S-1 filed April 1, 2026 targeting $75B Nasdaq IPO in June 2026 at $1.75T–$2T valuation — largest IPO in history. $15B combined revenue (SpaceX + xAI merger). Starlink: $10B revenue, 10M subscribers. Government contracts with NASA and DoD. 30% retail allocation.
| Industry | Aerospace & Defense |
| Stage | IPO Filed |
| IPO Status | Public |
| Valuation | $1.75T – $2T |
| Total Funding | $11.9B |
| Headquarters | Hawthorne, CA |
Precision mental health benefits platform for employers, using ML to personalize care.
| Industry | Healthcare Technology |
| Stage | Series F |
| IPO Status | Pre-IPO |
| Valuation | $3.3B |
| Total Funding | $370M |
| Headquarters | New York, NY |
SpaceX is valued at $1.75T – $2T. Spring Health is valued at $3.3B. Both valuations are based on the most recent private funding rounds tracked by TechStackIPO.
SpaceX has raised $11.9B. Spring Health has raised $370M.
SpaceX is currently already public. Spring Health is currently pre-IPO. Track both on TechStackIPO for S-1 filings and IPO announcements.
SpaceX operates in Aerospace & Defense, while Spring Health operates in Healthcare Technology.
SpaceX is a Aerospace & Defense company valued at $1.75T – $2T with $11.9B raised. Spring Health is a Healthcare Technology company valued at $3.3B with $370M raised. See TechStackIPO's full side-by-side comparison for IPO readiness scores, funding timelines, and investor data.
Accredited investors can access pre-IPO shares in SpaceX and Spring Health through secondary market platforms, pre-IPO funds, and broker-dealer platforms that facilitate private company transactions. TechStackIPO's marketplace section tracks available access options for both companies. Pre-IPO investments carry higher risk and limited liquidity.